8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.26%
Revenue growth above 1.5x 9843.T's 5.30%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
13.78%
Gross profit growth above 1.5x 9843.T's 5.36%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
60.88%
Positive EBIT growth while 9843.T is negative. John Neff might see a substantial edge in operational management.
78.82%
Positive operating income growth while 9843.T is negative. John Neff might view this as a competitive edge in operations.
59.23%
Positive net income growth while 9843.T is negative. John Neff might see a big relative performance advantage.
55.38%
Positive EPS growth while 9843.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
55.38%
Positive diluted EPS growth while 9843.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Share reduction while 9843.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 9843.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
385.68%
OCF growth above 1.5x 9843.T's 137.87%. David Dodd would confirm a clear edge in underlying cash generation.
294.03%
FCF growth 50-75% of 9843.T's 507.16%. Martin Whitman would see if structural disadvantages exist in generating free cash.
10.87%
10Y CAGR of 10.87% while 9843.T is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
10.87%
5Y CAGR of 10.87% while 9843.T is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
10.87%
3Y CAGR of 10.87% while 9843.T is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
20.32%
OCF/share CAGR of 20.32% while 9843.T is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
20.32%
OCF/share CAGR of 20.32% while 9843.T is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
20.32%
3Y OCF/share CAGR of 20.32% while 9843.T is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
23.37%
10Y net income/share CAGR of 23.37% while 9843.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
23.37%
Net income/share CAGR of 23.37% while 9843.T is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
23.37%
3Y net income/share CAGR of 23.37% while 9843.T is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
22.09%
Equity/share CAGR of 22.09% while 9843.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
22.09%
Equity/share CAGR of 22.09% while 9843.T is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
22.09%
Equity/share CAGR of 22.09% while 9843.T is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
-61.67%
Cut dividends over 10 years while 9843.T stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-61.67%
Negative 5Y dividend/share CAGR while 9843.T stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-61.67%
Negative near-term dividend growth while 9843.T invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
No Data
No Data available this quarter, please select a different quarter.
-0.54%
Inventory is declining while 9843.T stands at 2.66%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
10.14%
Asset growth above 1.5x 9843.T's 4.00%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
6.28%
BV/share growth above 1.5x 9843.T's 2.51%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
11.04%
We have some new debt while 9843.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.